Australia markets closed

Journey Medical Corporation (DERM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.4500-0.1700 (-4.70%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 72.30M
Enterprise value 63.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.90
Price/book (mrq)5.58
Enterprise value/revenue 0.79
Enterprise value/EBITDA 50.09

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3162.32%
S&P500 52-week change 326.36%
52-week high 38.1100
52-week low 31.0300
50-day moving average 33.6414
200-day moving average 33.8541

Share statistics

Avg vol (3-month) 3142.47k
Avg vol (10-day) 349.74k
Shares outstanding 513.97M
Implied shares outstanding 619.97M
Float 88.27M
% held by insiders 131.99%
% held by institutions 113.16%
Shares short (30 Apr 2024) 4283.29k
Short ratio (30 Apr 2024) 41.7
Short % of float (30 Apr 2024) 47.94%
Short % of shares outstanding (30 Apr 2024) 41.42%
Shares short (prior month 28 Mar 2024) 4148.09k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -5.20%
Operating margin (ttm)-77.44%

Management effectiveness

Return on assets (ttm)0.42%
Return on equity (ttm)-40.69%

Income statement

Revenue (ttm)80M
Revenue per share (ttm)4.27
Quarterly revenue growth (yoy)6.70%
Gross profit (ttm)N/A
EBITDA 4.18M
Net income avi to common (ttm)-4.16M
Diluted EPS (ttm)-0.1700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.06M
Total cash per share (mrq)1.21
Total debt (mrq)17.77M
Total debt/equity (mrq)137.19%
Current ratio (mrq)1.21
Book value per share (mrq)0.65

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A